ArticleCancer cell international2018

The tyrosine kinase inhibitor nilotinib is more efficient than mitotane in decreasing cell viability in spheroids prepared from adrenocortical carcinoma cells.

Elaine Silveira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.